It is a pharma private limited company based in Haryana, Haryana, India, established in 2002.
2002 | Haryana, Haryana, India | ActiveCoax Bioremedies Private Limited, a active private limited company, was established on 09 December 2002 in Haryana, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397HR2002PTC035005. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹1.00 Cr.
It upholds a compliant status. Employing 50 professional, Its leadership includes Harsh Vasudeva (Director), Atam Parkash Vasudeva (Director). Past directors included Subhash Chand. It holds ₹1.04 Cr open charges and ₹6.80 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 83Sector - 27 - 28 Hisar, Haryana, Haryana.
U51397HR2002PTC035005
035005
09 December 2002
₹1.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Coax Bioremedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Harsh Vasudeva | Director | 21 Sep 2009 | Current |
| Atam Parkash Vasudeva | Director | 09 Dec 2002 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Sep 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Coax Bioremedies Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 15.83% decrease. The company also saw a substantial fall in profitability, with a 63.39% decrease in profit. The company's net worth moved up by a moderate rise of 5.52%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Coax Bioremedies had a public holding of 51.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹10,400,000.00
₹6,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2019 | Others | ₹0.90 M | Open |
| 18 Nov 2003 | Others | ₹9.50 M | Open |
| 18 Dec 2003 | Punjab National Bank | ₹2.30 M | Satisfied |
| 18 Nov 2003 | Punjab National Bank | ₹4.17 M | Satisfied |
| 18 Nov 2003 | Punjab National Bank | ₹0.34 M | Satisfied |
Explore comprehensive loan charge details -
Coax Bioremedies has a workforce of 50 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Coax Bioremedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Coax Bioremedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Coax Bioremedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Coax Bioremedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
The activity A charge with Others amounted to Rs. 0.09 Cr with Charge ID 100309414 was registered on 26 Nov 2019. was completed.
The activity A charge with Others of Rs. 0.95 Cr registered on 18 Nov 2003 with Charge ID 80063673 was modified on 20 Dec 2018. was completed.
Progress on A charge registered on 18 Dec 2003 via Charge ID 90050264 with Punjab National Bank was fully satisfied on 19 Feb 2016. was documented.
A charge registered on 18 Nov 2003 via Charge ID 90050186 with Punjab National Bank was fully satisfied on 19 Feb 2016. was recorded as a recent event.
The CIN of Coax Bioremedies Private Limited is U51397HR2002PTC035005.
Coax Bioremedies Private Limited is headquartered at 83Sector - 27 - 28 Hisar, Haryana, Haryana.
Coax Bioremedies Private Limited was incorporated on 09 December 2002.
The current directors of Coax Bioremedies Private Limited are
The primary industry of Coax Bioremedies Private Limited is Manufacturing.
Coax Bioremedies Private Limited is unlisted.
The authorized capital of Coax Bioremedies Private Limited is ₹1.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Coax Bioremedies Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX